Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. AVDL has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
AVDL stock price ended at $8.7 on Friday, after rising1.05%
The Avadel Pharmaceuticals PLC stock price increased by 1.05% on the last trading day (02 May 2025), rising from 8.89 to 8.7. Throughout the last trading session, the stock experienced a fluctuation of 3.41% , ranging from a day low of $8.65 to a day high of 8.945. The price has declined in 4 of the last 10 days, resulting in a total change of 8.34% during this period. On the last day, trading volume decrease by -7.26K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 715.15K shares were traded, amounting to approximately 6.28M.
AVDL Technical Signals
AVDL(Avadel Pharmaceuticals PLC Corp) has 3 buy signals and 4 sell signals now. The current trend is downtrend starting from 2025-03-17. The total price change during this trend is -2.60%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of AVDL over the last 5 trading days is 7.58M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
AVDL Moving Average Analysis
Avadel Pharmaceuticals PLC's overall moving average trend leans more bearish as of Friday, May 2, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $9.125456666666667, and $9.566666666666666. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $7.697876666666667, and $7.256666666666667. A break-down below any of these levels will issue sell signals.
AVDL Short Selling Analysis
The short sale ratio of Avadel Pharmaceuticals PLC(AVDL) as of 30 Apr 2025 is 15.86%, dropping from last trading day. With decreasing price from 8.61 to 8.89. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Neutral
Sell
4
Buy
3
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.688
Bullish
Momentum (10 days)
MOM_10 > 0
0.46
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.234
Bullish
4 Bearish Signals
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 > 80
89.279
Bearish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 > 80
81.052
Bearish
Williams %R (14 days)
WILLR_14 > -20
-17.647
Bearish
Moving Average
Price crosses below 5-day SMA
--
Bearish
AVDL Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Avadel Pharmaceuticals PLC(AVDL), our algorithm predicts AVDL's 1-month price at $9.09, with an 3.64%upwardshift. Using a similarity score up to 96.96%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Avadel Pharmaceuticals PLC (AVDL.O) stock, as of Sunday, April 27, 2025 , forecasts a 3.64% change over the next month, based on its high correlation with WLY.N stock patterns. The similarity between their price movements over the analyzed periods is 96.96%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
AVDL
Future prediction
Up: 3.64%
WLY
Up: 3.64%Similarity: 96.96%
Name
Similarity
Up/Down
WLY.N
96.96%
+3.64%
XPEV.N
96.69%
+26.18%
ATRC.O
96.64%
+34.53%
NEOV.O
96.56%
+48.10%
THR.N
96.32%
+14.74%
MNOV.O
96.23%
+18.08%
VTGN.O
96.22%
-4.55%
MMSI.O
96.06%
-7.03%
OPRX.O
96.05%
-5.70%
WLK.N
95.96%
+5.97%
AVDL Seasonality Analysis
Based on AVDL's historical stock price data across all years, the probability of a positive return in May is54.55%, suggesting it maybe an ideal month to invest in AVDL. In contrast,Februaryoffers the highest probability of positive returns at63.64%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Avadel Pharmaceuticals PLC (AVDL.O) stock in February has the highest probability of a positive return (63.64%), while December has the lowest probability (20.00%).
Performance Seasonality
The chart shows Avadel Pharmaceuticals PLC. (AVDL)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy Avadel Pharmaceuticals PLC (AVDL.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. AVDL has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Avadel Pharmaceuticals PLC (AVDL.O) stock in a year?
The radar chart shows that buying Avadel Pharmaceuticals PLC (AVDL.O) stock in February has the highest probability of a positive return (63.64%), while December has the lowest probability (20.00%).
How has Avadel Pharmaceuticals PLC. (AVDL)'s stock price performed over the past three years?
AVDL's stock price rose by 101.71% in 2023,decreased by -26.40% in 2024, and went down by 21.27% in 2025.
Is AVDL a buy based on overall technical signals summary?
AVDL has 3 buy signals and 4 sell signals now. Overall the technical rating for AVDL is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of AVDL.
What is the trend of Avadel Pharmaceuticals PLC (AVDL)'s moving average?
Avadel Pharmaceuticals PLC's overall moving average trend leans more bearish as of May 02 2025, with 3 negative signals and 1 positive signal.
What is price prediction for AVDL stock next month?
The price prediction chart for Avadel Pharmaceuticals PLC (AVDL.O) stock, as of April 27 2025, forecasts a 3.64% change over the next month, based on its high correlation with WLY stock patterns. The similarity between their price movements over the analyzed periods is 96.96%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for AVDL Stock?
The price prediction for AVDL stock in 2025 is expected to range between **$9.50 and $10.50**. This forecast is based on the stock being undervalued and the anticipated recovery in Lumryz's growth trajectory.
What is price prediction 2030 for AVDL Stock?
The price prediction for AVDL stock by 2030 is approximately **$25 to $35 per share**. This estimate is based on the company's strong fundamentals, including improving patient demand metrics for LUMRYZ and a diversified supply chain. Analysts maintain a 'Strong Buy' rating with price targets suggesting significant upside potential.